Go Back   HER2 Support Group Forums > Articles of Interest
Register Gallery FAQ Members List Calendar Search Today's Posts Mark Forums Read

Thread Tools Display Modes
Old 08-13-2022, 09:02 AM   #1
Senior Member
Join Date: Nov 2005
Posts: 530
If you are looking for Evusheld (covid prophylactic)

In searching for covid’s therapeutics, the most important thing is be very persistent (but very polite) and prepare for lots of time waiting on the phone. No health provider has time or staff to do this, yourself or your champion has to do this search. Keep in mind that many health professionals (nurses, physicians, pharmacists, etc) are not even aware of Evusheld.

There are two web sites to search for Covid’s therapeutics, the official government site (https://covid-19-therapeutics-locato...ub.arcgis.com/) and commercial site (goodrx.com). On the government site, be patient for the pages to FINISH loading. Click on “Therapeutic Selector” box at the upper right corner and select Evusheld from the drop-down list. Click on the magnifying glass symbol to activate the location search box. Enter your zip code in the search box and confirm by click on listed area. Locations that has Evusheld in the selected area are listed on the right hand side. You need to go back to this sequence to search another city/area. Note that the user interface might change from time to time, so look for similar fields and steps if the info described above do not match completely.

As you go through the availability list, for large institutions (hospitals, etc), there is no info on who to call. Almost 100% of the time, the operator does not know either, so ask to talk to someone in these departments: pharmacy, covid line, covid ward, incoming patient triage, employee health. People there likely also do not know about Evusheld. Be sure to spell out the drug name fully, and mention that it’s a prophylactic covid drug. Don’t take the first “no”, but be very polite, people are stressed out and might have a bad day.

Once you locate somebody who knows about Evusheld, you will likely be told that Evusheld is only available for current or past patients at that institution. If you had been at that institution in the past for test, scanning, rehab, etc mention this and you might qualify. Before going there, you need a prescription from your doctor, and be sure to ask the institution to verify that they actually have dosage on hand. Also be sure to know the qualification (see fact sheet link below) requirement for the drug.

The availability list is updated weekly, and available locations (new and old) get on and off based on how they respond to government weekly reporting requests. Keep a copy of the list each week. Don’t get discouraged if you see 0 in the quantity field. Call that location anyway.

Incidentally, pharmacy might not be aware of expiration date of Evusheld has just been extended. Also it’s a two shots one to each side of the buttock, then wait an hour for any reaction, so be sure a pharmacy has a facility to do this.

The following papers should be of interest.

Efficacy of Antibodies and Antiviral Drugs against Omicron BA.2.12.1, BA.4, and BA.5 Subvariants




Best wishes to your search.
Nguyen is offline   Reply With Quote
Old 01-05-2023, 12:56 PM   #2
Senior Member
Join Date: Nov 2005
Posts: 530
The End of Evusheld


"...If you’re immunocompromised, this … isn’t great....


"...The XBB subvariants are also resistant to Evusheld, an antibody cocktail that many people with weak immune systems rely on for protection against Covid infection because they don’t mount a strong response to the vaccines...."

Nguyen is offline   Reply With Quote
Old 01-10-2023, 11:40 AM   #3
Senior Member
Join Date: Nov 2005
Posts: 530
New (1/10/23) Statement on Tixagevimab Plus Cilgavimab (Evusheld) Released

New(1/10/23) Statement on Tixagevimab Plus Cilgavimab (Evusheld) Released


The COVID-19 Treatment Guidelines Panel’s Statement on Tixagevimab Plus Cilgavimab (Evusheld) as Pre-Exposure Prophylaxis of COVID-19

Last Updated: January 10, 2023

The prevalence of SARS-CoV-2 Omicron subvariants likely to be resistant to tixagevimab plus cilgavimab (Evusheld) has been rapidly increasing in the United States. These subvariants are BA.2.75.2, BA.4.6, BA.5.2.6, BF.7, BF.11, BQ.1, BQ.1.1, and XBB.1 In addition, the XBB.1.5 subvariant is not anticipated to be neutralized by tixagevimab plus cilgavimab.2,3 As of January 6, 2023, the overall prevalence of these Omicron subvariants is estimated to be more than 91%.

Tixagevimab plus cilgavimab is authorized by the Food and Drug Administration (FDA) for pre-exposure prophylaxis (PrEP) of COVID-19 in people who are not expected to mount an adequate immune response to COVID-19 vaccination or people with contraindications for COVID-19 vaccination.

Due to the high prevalence of resistant Omicron subvariants in the United States, tixagevimab plus cilgavimab is unlikely to be effective at preventing COVID-19 in the vast majority of individuals, although it is still authorized by the FDA for COVID-19 PrEP. However, given the lack of alternative PrEP options, clinicians could still administer tixagevimab plus cilgavimab after considering an individual patient’s risks and the regional prevalence of the resistant subvariants.

Regardless of their use of tixagevimab plus cilgavimab, it is crucial that these high-risk patients:

Keep up to date with COVID-19 vaccination and boosters, unless contraindicated.
Take precautions to avoid infection.
Be tested for SARS-CoV-2 if they experience signs and symptoms consistent with COVID-19 and, if infected, promptly seek medical attention.
Nguyen is offline   Reply With Quote

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On

Forum Jump

All times are GMT -7. The time now is 05:13 PM.

Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter